Suchergebnisse - "Pourshohod, Aminollah"

PubPharm (8)

1

Investigating new inhibitors with potential advantages for combating HER2-overexpressing head and neck squamous cancer cells; a practical and virtual screening study

enthalten in: ResearchSquare.com | 2024

von Zeinali, M. | Pourshohod, A. | Barzegari, E. | +4

2

Simulation and practical investigation of carbonic anhydrase stability in an industrial solvent system of methyl diethanolamine for carbon dioxide capture

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Barzegari, E. | Ghaedizadeh, S. | Pourshohod, A. | +2

3

3D structure prediction, dynamic investigation and rational construction of an epitope-masked thermostable bovine hyaluronidase

enthalten in: International journal of biological macromolecules | 2021

von Amin, M. | Barzegari, E. | Pourshohod, A. | +2

4

Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by ZHER2-Idarubicin Conjugate : An in vitro Study

enthalten in: Iranian journal of pathology | 2021

von Siavoshinia, L. | Jamalan, M. | Zeinali, M. | +4

5

The Effect of the Hydroalcoholic Extract of Watercress on the Levels of Protein Carbonyl, Inflammatory Markers, and Vitamin E in Chronic Hemodialysis Patients

enthalten in: Biochemistry research international | 2021

von Sedaghattalab, M. | Razazan, M. | Shahpari, M. | +9

6

Effects of Nasturtium officinale Extract on Antioxidant and Biochemical Parameters in Hemodialysis Patients : A Randomized Double-Blind Clinical Trial

enthalten in: Evidence-based complementary and alternative medicine : eCAM | 2021

von Sedaghattalab, M. | Razazan, M. | Sadeghi, H. | +8

7

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

enthalten in: Current cancer drug targets | 2019

von Ghanemi, M. | Pourshohod, A. | Ghaffari, M. | +4

8

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

enthalten in: Current cancer drug targets | 2019

von Ghanemi, M. | Pourshohod, A. | Ghaffari, M. | +4

1
[1]